Search

everythinglearnresearchcommunity

for

Search:↓

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

CT scans can find serious prostate cancer even when PSA levels are low.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Men with better urinary symptoms have a lower risk of death.

Treatments for urinary symptoms often cause ejaculatory problems.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.